Oral triptans in children and adolescents: an update.

This review evaluates the recent progress in clinical trials on oral triptans for acute migraine in children and adolescents. Randomized controlled trials (RCT) on the treatment of migraine in pediatric patients were rare and difficult to design. In particular, high placebo response in many of the trials made it difficult to prove efficacy of triptans. Using a "novel study design" for RCT, a study successfully proved the efficacy of an oral rizatriptan. This trial enrolled patients with unsatisfactory response to nonsteroidal anti-inflammatory or acetaminophen and with migraine lasting longer than 3 h. Rizatriptan was approved by Food and Drug Administration (FDA) (USA) for children and adolescents of 6-17 years. The triptan-NSAID combination drug for pediatric patients also showed efficacy.
AuthorsFumihiko Sakai
JournalCurrent pain and headache reports (Curr Pain Headache Rep) Vol. 19 Issue 3 Pg. 8 (Mar 2015) ISSN: 1534-3081 [Electronic] United States
PMID25754598 (Publication Type: Journal Article, Review)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Triazoles
  • Tryptamines
  • Acetaminophen
  • rizatriptan
  • Acetaminophen (administration & dosage)
  • Administration, Oral
  • Adolescent
  • Anti-Inflammatory Agents, Non-Steroidal (administration & dosage)
  • Child
  • Dose-Response Relationship, Drug
  • Humans
  • Migraine Disorders (drug therapy)
  • Randomized Controlled Trials as Topic
  • Treatment Outcome
  • Triazoles (administration & dosage)
  • Tryptamines (administration & dosage)
  • United States
  • United States Food and Drug Administration

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: